Page last updated: 2024-12-07
sk&f 83742
Description
Research Excerpts
Clinical Trials
Roles
Classes
Pathways
Study Profile
Bioassays
Related Drugs
Related Conditions
Protein Interactions
Research Growth
Market Indicators
Description
SK&F 83742: dopaminergic ligand; RN given refers to parent cpd [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
Cross-References
| ID Source | ID |
|---|---|
| PubMed CID | 130828 |
| CHEMBL ID | 1194482 |
| SCHEMBL ID | 10471907 |
| MeSH ID | M0109170 |
Synonyms (12)
| Synonym |
|---|
| skf 83742 |
| 2,3,4,5-tetrahydro-3-methyl-6-(phenylthio)-1h-3-benzazepine-7,8-diol |
| 73943-42-7 |
| CHEMBL1194482 |
| sk&f 83742 |
| 1h-3-benzaepine-7,8-diol, 2,3,4,5-tetrahydro-3-methyl-6-(phenylthio)- |
| sk&f-83742 |
| 1h-3-benzazepine-7,8-diol, 2,3,4,5-tetrahydro-3-methyl-6-(phenylthio)- |
| 2,3,4,5-tetrahydro-3-methyl-6-(phenylthio)-1h-3-benzaepine-7,8-diol |
| SCHEMBL10471907 |
| 3-methyl-6-(phenylsulfanyl)-2,3,4,5-tetrahydro-1h-3-benzazepine-7,8-diol |
| DTXSID40995168 |
Research Excerpts
Dosage Studied
| Excerpt | Relevance | Reference |
|---|---|---|
| " The dose-response curve for dopamine to stimulate the heart rate (HR) closely resembled that for the norepinephrine release." | ( The mechanisms underlying heart stimulation by dopamine, with special reference to direct and indirect beta adrenoceptor stimulation. Habuchi, Y; Komori, T; Nishio, M; Tanaka, H; Yamamoto, T; Yoshimura, M, ) | 0.13 |
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
Research
Studies (4)
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 1 (25.00) | 18.7374 |
| 1990's | 3 (75.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
Market Indicators
Research Demand Index: 12.81
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (12.81) All Compounds (24.57) |
Study Types
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 6 (100.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||